Trials / Completed
CompletedNCT04480671
Impact of Level III Support Procedure on Enlarged Genital Hiatus After Minimally Invasive Sacrocolpopexy
Impact of Level III Support Procedure on Normalization of Enlarged Genital Hiatus After Minimally Invasive Sacrocolpopexy: a Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 94 (actual)
- Sponsor
- University of Pittsburgh · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized controlled surgical trial evaluating the use of a concomitant posterior colporrhaphy and/or perineorrhaphy at the conclusion of minimally invasive sacrocolpopexy to narrow enlarged genital hiatuses in a population of women with pelvic organ prolapse. The study's primary outcome is the proportion of women at 6 months postoperatively who still have an enlarged genital hiatus. An exploratory sub-aim (as of October 2021) of the study is to evaluate the levator hiatal area as compared with the genital hiatus by using preoperative and postoperative transperineal ultrasounds. Subjects will be invited to participate, but is not required for study participation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Level III support procedure | A level III support procedure is aimed at repairing the distal support of the vagina with either a posterior colporrhaphy and/or a perineorrhaphy. |
| PROCEDURE | Minimally Invasive Sacrocolpopexy | All study participants are planning with their surgeon a minimally invasive sacrocolpopexy (robotic or laparoscopic) to repair pelvic organ prolapse. |
| OTHER | Transperineal ultrasound of the Pelvic Floor | Subjects from either arm will be invited to participate in this exploratory arm of the study. If they choose to participate, they will have a preoperative ultrasound performed and an ultrasound performed at the time of their 6 month visit. |
Timeline
- Start date
- 2020-08-26
- Primary completion
- 2023-02-02
- Completion
- 2024-07-25
- First posted
- 2020-07-21
- Last updated
- 2024-10-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04480671. Inclusion in this directory is not an endorsement.